Possible predisposition of diabetic patients to hyperkalemia following administration of potassium-retaining diuretic, amiloride (MK 870).
D000328:Adult; D000368:Aged; D001639:Bicarbonates / Q000097:blood; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D002712:Chlorides / Q000097:blood; D003404:Creatinine / Q000097:blood; D003920:Diabetes Mellitus / Q000188:drug therapy; D004232:Diuretics / Q000009:adverse effects; D004562:Electrocardiography; D005260:Female; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000097:blood; D011719:Pyrazines / Q000009:adverse effects*; D012964:Sodium / Q000097:blood; D013148:Spironolactone / Q000009:adverse effects; D014223:Triamterene / Q000009:adverse effects; D014882:Water-Electrolyte Balance / Q000187:drug effects
D001639:Bicarbonates; D002712:Chlorides; D004232:Diuretics; D011719:Pyrazines; D013148:Spironolactone; D012964:Sodium; D003404:Creatinine; D011188:Potassium; D014223:Triamterene